| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Anika Therapeutics, Inc. (ANIK) has 12 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. ANIK is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 217.3K | $3.29M | - | |
| VP | 55.0K | $832.7K | - | |
| Dir | 54.9K | $830.5K | +5.0K | |
| Dir | 50.3K | $760.7K | - | |
| Dir | 50.2K | $760.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 10, 2020 | Land Raymond J | Director | Sell | 3,446 | $36.77 | $126,709.42 | -25.7% | |
| Jul 9, 2020 | Loerop James | EVP Business Development | Sell | 1,244 | $35.15 | $43,726.60 | -41.5% | |
| Feb 26, 2020 | Land Raymond J | Director | Sell | 2,700 | $42.68 | $115,236.00 | -16.8% | |
| Nov 8, 2019 | Cheung Sylvia | Chief Financial Officer | Sale+OE | 20,000 | $59.71 | $1,194,200.00 | -29.5% | |
| Aug 28, 2019 | Larsen Glenn R. | Director | Sell | 4,355 | $57.21 | $249,149.55 | -36.5% | |
| Aug 20, 2019 | Bower Joseph L. | Director | Sell | 1,994 | $55.57 | $110,806.58 | -4.4% | |
| Aug 8, 2019 | Thompson Jeffery S | Director | Sell | 4,843 | $56.66 | $274,404.38 | -41.4% | |
| Jul 29, 2019 | Land Raymond J | Director | Sell | 3,000 | $55.44 | $166,320.00 | -20.0% | |
| Feb 28, 2019 | Darling Joseph G | President And Ceo; Director | Buy | 1,000 | $33.20 | $33,200.00 | +4.7% | |
| Feb 26, 2019 | Land Raymond J | Director | Sell | 4,000 | $33.06 | $132,240.00 | -21.1% |